Developed by Shray Alag, The Harker School
Sections: Correlations,
Clinical Trials, and HPO
Navigate: Clinical Trials and HPO
Name (Synonyms) | Correlation | |
---|---|---|
drug1237 | DWJ1248 Wiki | 1.00 |
drug987 | Chronic Disease Self-Management Program Wiki | 1.00 |
drug3195 | Placebo Wiki | 0.04 |
Name (Synonyms) | Correlation | |
---|---|---|
D002908 | Chronic Disease NIH | 0.26 |
D001523 | Mental Disorders NIH | 0.19 |
Name (Synonyms) | Correlation |
---|
Navigate: Correlations HPO
There is one clinical trial.
The study will enroll 600 people with serious mental illness who receive services at Centerstone in KY or TN and will compare two different evidence-based self-management interventions: Integrated Illness Management and Recovery (I-IMR), a program developed by the study team at Dartmouth that trains people with serious mental illness on physical and mental health self-management, and the Stanford Chronic Disease Self-Management Program (CDSMP), a program largely focused on physical health self-management that has been used widely in the general population. In addition, PCORI is funding an evaluation of a COVID-related intervention that will begin in the Fall 2020.
Description: Change in knowledge and skills for illness self-management. Range of scores from 15-75 with higher scores meaning better illness self-management.
Measure: Change in Knowledge and skills in illness self-management using the Illness Management and Recovery Scale Time: Change from Baseline to 12 monthsDescription: Change in Patient Activation (engagement in health care). Maximum score of 100, higher scores meaning greater activation.
Measure: Change in Patient Activation on the Patient Activation Measure (PAM) Time: Change from Baseline to 12 monthsDescription: Change in the number of acute hospital events. At each assessment a combination of participant report and verified information from mental health clinics will be used to validate the number acute hospital events.
Measure: Change in Acute Hospital Events from Electronic Medical Record Review. Time: Change from Baseline to 12 monthsDescription: Change in score on this measure, which was developed as part of the study plan because no suitable scale existed to assess knowledge and safety behaviors for COVID-19. Scores range from 0-100%, with higher scores indicating greater knowledge and enactment of safety behaviors.
Measure: Knowledge and Behaviors for Preventing Catching and Spreading COVID-19 Scale Time: Change from Baseline to 12 weeksAlphabetical listing of all HPO terms. Navigate: Correlations Clinical Trials
Data processed on December 13, 2020.
An HTML report was created for each of the unique drugs, MeSH, and HPO terms associated with COVID-19 clinical trials. Each report contains a list of either the drug, the MeSH terms, or the HPO terms. All of the terms in a category are displayed on the left-hand side of the report to enable easy navigation, and the reports contain a list of correlated drugs, MeSH, and HPO terms. Further, all reports contain the details of the clinical trials in which the term is referenced. Every clinical trial report shows the mapped HPO and MeSH terms, which are also hyperlinked. Related HPO terms, with their associated genes, protein mutations, and SNPs are also referenced in the report.
Drug Reports MeSH Reports HPO Reports